Please login to the form below

Not currently logged in
Email:
Password:

Thomas Wellner appointed CEO of CML Healthcare

Former president and general manager of Lilly Germany joins Canada-based provider of laboratory testing services

Former president and general manager of Lilly Germany Thomas Wellner has been appointed CEO of CML Healthcare.

Wellner takes over from company chair Patrice Merrin, who had been interim CEO of the Canada-based provider of laboratory testing services since May, 2011.

"We are very pleased to welcome Tom Wellner to CML,” said Merrin. “During the course of his career, Tom has had exposure to numerous healthcare and payor systems as well as to the critical interface of diagnostics, physicians, patients and treatment regimens.”

Prior to his new appointment, Wellner was president and CEO of Canadian biopharma Therapure Biopharma, from 2008 to 2011.

Before his time at Theapure he spent a total of 20 years at Eli Lilly & Company holding senior roles in China, the US, the UK and Latin America.

These included executive director marketing and sales, European Operations at Eli Lilly and Company and director marketing at Eli Lilly Canada, as well as his position in Germany.

9th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics